Apogee Therapeutics Inc. (APGE)

전일 마감가:

$52.22

열려 있는:

$51.33

하루 거래량:

177.64K

시가총액:

$2.89B

수익:

-

순이익/손실:

$-71.91M

주가수익비율:

-

EPS:

-

순현금흐름:

-

1주 성능:

+0.69%

1개월 성능:

-6.10%

6개월 성능:

+216.42%

1년 성능:

+0.00%

1일 변동 폭

$49.57

$52.23

52주 변동 폭

$14.19

$72.29

Apogee Therapeutics Inc. Stock (APGE) Company Profile

명칭

Apogee Therapeutics Inc.

부문

Healthcare (1213)

산업

Biotechnology (697)

전화

650-394-5230

주소

221 Crescent Street, Building 17 Suite 102b, Waltham

직원

0

트위터

다음 수익 날짜

최신 SEC 제출 서류

APGE's Discussions on Twitter

Apogee Therapeutics Inc. Stock (APGE) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-20	개시	BTIG Research	Buy
2023-08-08	개시	Guggenheim	Buy
2023-08-08	개시	Jefferies	Buy
2023-08-08	개시	Stifel	Buy
2023-08-08	개시	TD Cowen	Outperform
2023-08-08	개시	Wedbush	Outperform

모두보기

Apogee Therapeutics Inc. 주식(APGE)의 최신 뉴스

Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference

GlobeNewswire Inc.

Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why

Zacks Investment Research

Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases

GlobeNewswire Inc.

Top 3 Health Care Stocks That Are Ticking Portfolio Bombs

Benzinga

Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million

GlobeNewswire Inc.

Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering

GlobeNewswire Inc.

Apogee Therapeutics Inc. (APGE) 재무 분석

Apogee Therapeutics Inc. (APGE) 순이익 2024

Apogee Therapeutics Inc. (APGE) 주당 순이익 2024

Apogee Therapeutics Inc. 주식 (APGE) 내부자 거래